[144] Twist Bioscience Corporation SEC Filing
Form 144 filed for Twist Bioscience Corporation (TWST) reporting an intended sale of common stock. The notice shows 1,840 shares to be sold through Fidelity Brokerage Services with an aggregate market value of $47,774.13 and an approximate sale date of 08/21/2025. The shares were acquired on 08/20/2025 via restricted stock vesting and relate to compensation. The issuer has 60,360,925 shares outstanding per the form. Recent disposals by the same person, Patrick Finn, are listed: 1,877 shares (05/21/2025, $55,835.87), 209 shares (07/02/2025, $7,564.36), 2,232 shares (07/23/2025, $79,773.02), and 3,189 shares (08/04/2025, $90,453.11).
Modulo 144 depositato per Twist Bioscience Corporation (TWST) relativo a una vendita prevista di azioni ordinarie. L’avviso indica la vendita di 1.840 azioni tramite Fidelity Brokerage Services per un valore di mercato complessivo di $47.774,13 e una data di vendita prevista approssimativa del 21/08/2025. Le azioni sono state acquisite il 20/08/2025 mediante vesting di azioni soggette a restrizioni e sono collegate a compensi. L’emittente segnala 60.360.925 azioni in circolazione secondo il modulo. Sono inoltre elencate cessioni recenti da parte della stessa persona, Patrick Finn: 1.877 azioni (21/05/2025, $55.835,87), 209 azioni (02/07/2025, $7.564,36), 2.232 azioni (23/07/2025, $79.773,02) e 3.189 azioni (04/08/2025, $90.453,11).
Se presentó el Formulario 144 para Twist Bioscience Corporation (TWST) notificando una intención de vender acciones ordinarias. El aviso muestra 1.840 acciones que se venderán a través de Fidelity Brokerage Services por un valor de mercado agregado de $47.774,13 y una fecha aproximada de venta del 21/08/2025. Las acciones se adquirieron el 20/08/2025 mediante vesting de acciones restringidas y están relacionadas con compensación. El emisor declara tener 60.360.925 acciones en circulación según el formulario. Se listan disposiciones recientes por la misma persona, Patrick Finn: 1.877 acciones (21/05/2025, $55.835,87), 209 acciones (02/07/2025, $7.564,36), 2.232 acciones (23/07/2025, $79.773,02) y 3.189 acciones (04/08/2025, $90.453,11).
Twist Bioscience Corporation(TWST)에 대해 Form 144가 제출되어 보통주 매각 의사가 보고되었습니다. 공지에 따르면 Fidelity Brokerage Services를 통해 1,840주를 매도할 예정이며 총 시가총액은 $47,774.13, 예상 매각일은 2025-08-21입니다. 해당 주식은 2025-08-20에 제한부 주식의 베스팅(vesting)으로 취득되었으며 보상과 관련되어 있습니다. 발행회사는 해당 서식에 따라 60,360,925주 유통 중이라고 명시되어 있습니다. 동일인(Patrick Finn)의 최근 처분 내역도 기재되어 있습니다: 1,877주(2025-05-21, $55,835.87), 209주(2025-07-02, $7,564.36), 2,232주(2025-07-23, $79,773.02), 3,189주(2025-08-04, $90,453.11).
Formulaire 144 déposé pour Twist Bioscience Corporation (TWST) signalant une intention de vente d’actions ordinaires. L’avis indique 1 840 actions devant être vendues via Fidelity Brokerage Services pour une valeur de marché totale de 47 774,13 $ et une date de vente approximative au 21/08/2025. Les actions ont été acquises le 20/08/2025 par vesting d’actions restreintes et sont liées à une rémunération. L’émetteur déclare 60 360 925 actions en circulation selon le formulaire. Sont également listées des cessions récentes par la même personne, Patrick Finn : 1 877 actions (21/05/2025, 55 835,87 $), 209 actions (02/07/2025, 7 564,36 $), 2 232 actions (23/07/2025, 79 773,02 $) et 3 189 actions (04/08/2025, 90 453,11 $).
Formular 144 eingereicht für Twist Bioscience Corporation (TWST) mit der Meldung einer beabsichtigten Veräußerung von Stammaktien. Die Mitteilung weist 1.840 Aktien aus, die über Fidelity Brokerage Services verkauft werden sollen, mit einem Gesamtmarktwert von $47.774,13 und einem ungefähren Verkaufsdatum am 21.08.2025. Die Aktien wurden am 20.08.2025 durch Vesting von eingeschränkten Aktien erworben und stehen im Zusammenhang mit Vergütung. Der Emittent gibt im Formular 60.360.925 ausstehende Aktien an. Außerdem sind jüngste Veräußerungen derselben Person, Patrick Finn, aufgeführt: 1.877 Aktien (21.05.2025, $55.835,87), 209 Aktien (02.07.2025, $7.564,36), 2.232 Aktien (23.07.2025, $79.773,02) und 3.189 Aktien (04.08.2025, $90.453,11).
- None.
- None.
Insights
TL;DR: Routine insider sale from restricted stock vesting; amounts are small relative to outstanding shares and appear non-material.
The filing documents a proposed sale of 1,840 common shares by an insider via a broker, acquired the prior day through restricted stock vesting and characterized as compensation. The form also discloses four prior small sales totaling 7,507 shares over the past three months with disclosed gross proceeds. Compared with the reported 60,360,925 shares outstanding, these transactions represent an immaterial ownership shift and are consistent with typical post-vesting selling activity rather than a company-level development.
TL;DR: Disclosure aligns with Rule 144 requirements; signer affirms no undisclosed material information.
The notice includes the required Rule 144 details: acquisition date, nature of acquisition (restricted stock vesting), broker name, and recent sales history for the reporting person, Patrick Finn. The signature/representation language affirms absence of undisclosed material information. There is no indication of a trading plan date on the form, and nothing in this filing signals governance changes or regulatory concerns.
Modulo 144 depositato per Twist Bioscience Corporation (TWST) relativo a una vendita prevista di azioni ordinarie. L’avviso indica la vendita di 1.840 azioni tramite Fidelity Brokerage Services per un valore di mercato complessivo di $47.774,13 e una data di vendita prevista approssimativa del 21/08/2025. Le azioni sono state acquisite il 20/08/2025 mediante vesting di azioni soggette a restrizioni e sono collegate a compensi. L’emittente segnala 60.360.925 azioni in circolazione secondo il modulo. Sono inoltre elencate cessioni recenti da parte della stessa persona, Patrick Finn: 1.877 azioni (21/05/2025, $55.835,87), 209 azioni (02/07/2025, $7.564,36), 2.232 azioni (23/07/2025, $79.773,02) e 3.189 azioni (04/08/2025, $90.453,11).
Se presentó el Formulario 144 para Twist Bioscience Corporation (TWST) notificando una intención de vender acciones ordinarias. El aviso muestra 1.840 acciones que se venderán a través de Fidelity Brokerage Services por un valor de mercado agregado de $47.774,13 y una fecha aproximada de venta del 21/08/2025. Las acciones se adquirieron el 20/08/2025 mediante vesting de acciones restringidas y están relacionadas con compensación. El emisor declara tener 60.360.925 acciones en circulación según el formulario. Se listan disposiciones recientes por la misma persona, Patrick Finn: 1.877 acciones (21/05/2025, $55.835,87), 209 acciones (02/07/2025, $7.564,36), 2.232 acciones (23/07/2025, $79.773,02) y 3.189 acciones (04/08/2025, $90.453,11).
Twist Bioscience Corporation(TWST)에 대해 Form 144가 제출되어 보통주 매각 의사가 보고되었습니다. 공지에 따르면 Fidelity Brokerage Services를 통해 1,840주를 매도할 예정이며 총 시가총액은 $47,774.13, 예상 매각일은 2025-08-21입니다. 해당 주식은 2025-08-20에 제한부 주식의 베스팅(vesting)으로 취득되었으며 보상과 관련되어 있습니다. 발행회사는 해당 서식에 따라 60,360,925주 유통 중이라고 명시되어 있습니다. 동일인(Patrick Finn)의 최근 처분 내역도 기재되어 있습니다: 1,877주(2025-05-21, $55,835.87), 209주(2025-07-02, $7,564.36), 2,232주(2025-07-23, $79,773.02), 3,189주(2025-08-04, $90,453.11).
Formulaire 144 déposé pour Twist Bioscience Corporation (TWST) signalant une intention de vente d’actions ordinaires. L’avis indique 1 840 actions devant être vendues via Fidelity Brokerage Services pour une valeur de marché totale de 47 774,13 $ et une date de vente approximative au 21/08/2025. Les actions ont été acquises le 20/08/2025 par vesting d’actions restreintes et sont liées à une rémunération. L’émetteur déclare 60 360 925 actions en circulation selon le formulaire. Sont également listées des cessions récentes par la même personne, Patrick Finn : 1 877 actions (21/05/2025, 55 835,87 $), 209 actions (02/07/2025, 7 564,36 $), 2 232 actions (23/07/2025, 79 773,02 $) et 3 189 actions (04/08/2025, 90 453,11 $).
Formular 144 eingereicht für Twist Bioscience Corporation (TWST) mit der Meldung einer beabsichtigten Veräußerung von Stammaktien. Die Mitteilung weist 1.840 Aktien aus, die über Fidelity Brokerage Services verkauft werden sollen, mit einem Gesamtmarktwert von $47.774,13 und einem ungefähren Verkaufsdatum am 21.08.2025. Die Aktien wurden am 20.08.2025 durch Vesting von eingeschränkten Aktien erworben und stehen im Zusammenhang mit Vergütung. Der Emittent gibt im Formular 60.360.925 ausstehende Aktien an. Außerdem sind jüngste Veräußerungen derselben Person, Patrick Finn, aufgeführt: 1.877 Aktien (21.05.2025, $55.835,87), 209 Aktien (02.07.2025, $7.564,36), 2.232 Aktien (23.07.2025, $79.773,02) und 3.189 Aktien (04.08.2025, $90.453,11).